Bayer backs broadened effort to shield popular weedkiller from claims it failed to warn of cancer
A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its popular weedkiller ...
pharmaphorum6d
Bayer adds menopause drug to pipeline with KaNDy acquisition
Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s menopause drug to its women’s health pipeline. Bayer will pay $425 million up front and ...
Hosted on MSN1mon
Bayer’s Eye Drug Shows Positive Results in Late-Stage Trial
The treatment led to rapid, robust reduction of fluid in the retina in patients with macular edema following retinal vein occlusion, Bayer said. The high-dose drug has the potential to become a ...